Todd Carter's most recent trade in Houlihan Lokey Inc - Ordinary Shares - Class A was a trade of 2,645 CLASS B COMMON STOCK done . Disclosure was reported to the exchange on May 22, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Houlihan Lokey Inc - Ordin... | Todd J. Carter | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 May 2025 | 2,645 | 2,645 | - | - | CLASS B COMMON STOCK | |
| Houlihan Lokey Inc - Ordin... | Todd J. Carter | Director | 22 May 2025 | 2,645 | 89,905 | - | - | CLASS B COMMON STOCK | ||
| Houlihan Lokey Inc - Ordin... | Todd J. Carter | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 15 May 2025 | 14,229 | 87,260 | - | - | CLASS B COMMON STOCK | |
| Voyager Therapeutics Inc | Todd Carter | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2025 | 92,000 | 92,000 | - | - | Stock Option (Right to Buy) | |
| Voyager Therapeutics Inc | Todd Carter | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2025 | 46,000 | 123,718 (0%) | 0% | 0 | Common Stock | |
| Voyager Therapeutics Inc | Todd Carter | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 4.26 per share. | 20 Feb 2025 | 3,305 | 77,718 (0%) | 0% | 4.3 | 14,079 | Common Stock |
| Voyager Therapeutics Inc | Todd Carter | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 4.45 per share. | 11 Feb 2025 | 5,413 | 81,023 (0%) | 0% | 4.5 | 24,088 | Common Stock |
| Voyager Therapeutics Inc | Todd Carter | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 5.13 per share. | 14 Jan 2025 | 1,191 | 86,436 (0%) | 0% | 5.1 | 6,110 | Common Stock |
| Houlihan Lokey Inc - Ordin... | Todd J. Carter | Director | 23 May 2024 | 11,188 | 101,489 | - | - | CLASS B COMMON STOCK | ||
| Houlihan Lokey Inc - Ordin... | Todd J. Carter | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 May 2024 | 11,188 | 11,188 | - | - | CLASS B COMMON STOCK | |
| Houlihan Lokey Inc - Ordin... | Todd J. Carter | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 15 May 2024 | 13,107 | 90,301 | - | - | CLASS B COMMON STOCK | |
| Voyager Therapeutics Inc | Todd Carter | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 7.47 per share. | 20 Feb 2024 | 3,365 | 87,627 (0%) | 0% | 7.5 | 25,137 | Common Stock |
| Voyager Therapeutics Inc | Carter Todd | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 7.68 per share. | 20 Feb 2024 | 602 | 90,992 (0%) | 0% | 7.7 | 4,623 | Common Stock |
| ModivCare Inc | J. Carter Todd | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2024 | 2,658 | 16,777 (0%) | 0% | 0 | Common Stock | |
| Voyager Therapeutics Inc | Todd Carter | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Feb 2024 | 77,000 | 77,000 | - | - | Stock Option (Right to Buy) | |
| Voyager Therapeutics Inc | Carter Todd | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Feb 2024 | 38,500 | 91,594 (0%) | 0% | 0 | Common Stock | |
| Voyager Therapeutics Inc | Todd Carter | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 7.18 per share. | 17 Jan 2024 | 1,266 | 53,094 (0%) | 0% | 7.2 | 9,090 | Common Stock |
| Voyager Therapeutics Inc | Todd Carter | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 10.80 per share. | 06 Jul 2023 | 5,500 | 59,860 (0%) | 0% | 10.8 | 59,400 | Common Stock |
| Voyager Therapeutics Inc | Todd Carter | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Jun 2023 | 5,000 | 45,000 | - | - | Stock Option (Right to Buy) | |
| Voyager Therapeutics Inc | Todd Carter | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 11.41 per share. | 30 Jun 2023 | 5,000 | 65,360 (0%) | 0% | 11.4 | 57,050 | Common Stock |
| Voyager Therapeutics Inc | Todd Carter | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.85 per share. | 30 Jun 2023 | 5,000 | 70,360 (0%) | 0% | 2.9 | 14,250 | Common Stock |
| Houlihan Lokey Inc - Ordin... | Todd J. Carter | Director | 24 May 2023 | 12,303 | 103,408 | - | - | CLASS B COMMON STOCK | ||
| Houlihan Lokey Inc - Ordin... | Todd J. Carter | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 May 2023 | 12,303 | 12,303 | - | - | CLASS B COMMON STOCK | |
| Houlihan Lokey Inc - Ordin... | Todd J. Carter | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 15 May 2023 | 10,531 | 91,105 | - | - | CLASS B COMMON STOCK | |
| Voyager Therapeutics Inc | Todd Carter | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 7.76 per share. | 20 Mar 2023 | 2,193 | 65,360 (0%) | 0% | 7.8 | 17,018 | Common Stock |
| Voyager Therapeutics Inc | Todd Carter | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Feb 2023 | 68,000 | 68,000 | - | - | Stock Option (Right to Buy) | |
| Voyager Therapeutics Inc | Todd Carter | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Feb 2023 | 34,000 | 68,291 (0%) | 0% | 0 | Common Stock | |
| Voyager Therapeutics Inc | Todd Carter | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 7.45 per share. | 17 Feb 2023 | 738 | 67,553 (0%) | 0% | 7.4 | 5,498 | Common Stock |
| ModivCare Inc | Todd J. Carter | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2023 | 1,314 | 14,119 (0%) | 0% | 0 | Common Stock | |
| Voyager Therapeutics Inc | Todd Carter | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 7.67 per share. | 13 Feb 2023 | 797 | 34,291 (0%) | 0% | 7.7 | 6,113 | Common Stock |
| Voyager Therapeutics Inc | Todd Carter | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 9.57 per share. | 17 Jan 2023 | 706 | 35,488 (0%) | 0% | 9.6 | 6,756 | Common Stock |
| Voyager Therapeutics Inc | Todd Carter | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 10.34 per share. | 17 Jan 2023 | 400 | 35,088 (0%) | 0% | 10.3 | 4,136 | Common Stock |
| Voyager Therapeutics Inc | Todd Carter | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 5.17 per share. | 06 Jan 2023 | 388 | 36,582 (0%) | 0% | 5.2 | 2,006 | Common Stock |
| Voyager Therapeutics Inc | Todd Carter | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 6.41 per share. | 06 Jan 2023 | 388 | 36,194 (0%) | 0% | 6.4 | 2,487 | Common Stock |
| Voyager Therapeutics Inc | Todd Carter | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Sep 2022 | 165,000 | 165,000 | - | - | Stock Option (Right to Buy) | |
| ModivCare Inc | Todd J. Carter | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Feb 2022 | 1,223 | 12,805 (0%) | 0% | 0 | Common Stock | |
| ModivCare Inc | Todd J. Carter | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2021 | 725 | 11,582 (0%) | 0% | 0 | Common Stock |